Ep53: Phil Sharp

Episode Summary

Executive Summary: Phil Sharp traces his path from a Kentucky farm to Nobel-winning biologist and biotech pioneer, emphasizing how rural work ethic, self-directed learning, and cross-disciplinary curiosity shaped his scientific career. He recounts the road to discovering RNA splicing, the excitement of early molecular biology, and how that science fed into the founding and growth of Biogen, one of biotech’s foundational companies.

Main Topics: Rural upbringing and formative values: Sharp describes growing up on a small Kentucky farm, where routine labor, frugality, honesty, and teamwork shaped his character and sense of responsibility. Early interest in science and self-directed education: He explains that science interest began around age 11, driven by math, books, school libraries, and the Sputnik/NASA era rather than formal guidance or elite academic expectations. College and graduate training in chemistry: Sharp chose Union College, then the University of Illinois, where he shifted from physical chemistry toward molecular biology, learning to bridge disciplines and overcome early academic setbacks. Caltech postdoc and move into molecular biology: At Caltech with Norman Davidson and others, Sharp used physical chemistry tools to study DNA, plasmids, deletions, and transposable elements, solidifying his decision to work in molecular biology and cell biology. MIT years and the RNA splicing discovery: Sharp recounts the early 1970s environment at MIT and the discovery of discontinuous genes/splicing, which overturned one-gene-one-protein thinking and opened a new understanding of RNA processing. Founding and evolution of Biogen: He describes early conversations with Ray Schaefer, the Genentech precedent, the Geneva scientific meetings, and Biogen’s transition from broad ambition to focused product strategy under later leadership. Advice, identity, and humility: In reflecting on his younger self, Sharp says greater confidence might have helped, but emphasizes that his career succeeded through exploration, relationships, and recognizing his own talent over time.

Key Arguments: A rural upbringing can build the discipline, independence, and teamwork needed for scientific and entrepreneurial success. Self-directed reading and curiosity can compensate for limited educational resources and open a path into science. Cross-disciplinary training in physical chemistry gave Sharp tools to make unique contributions in molecular biology. Scientific progress often comes from working at the interface of new tools and important biological questions. RNA splicing fundamentally changed biology by revealing that genes are discontinuous and that one gene can yield multiple proteins. Biogen’s success required moving from broad visionary ambition to focused development of a few clinically viable products. The biotech industry was built by scientists who combined discovery, company-building, and long-term relationship networks.

Data Points: Farm size: 140-150 acres - Sharp’s family farm in northern Kentucky Siblings: 2 sisters - Sharp’s family structure growing up School class size (freshman year): 16 students - Small local public school before consolidation Consolidated county school size: 65 students - Pendleton County school after consolidation College attendees from class: About 6 to 12 of 65 - Sharp notes limited college-going in his community Age when science interest began: About 11 - He says interest in numbers and science started young Age when he started saving for college: 5 to 7 years old - He began saving early, including money from livestock and tobacco acreage Amount paid for first calf: $16.75 - He bought a heifer calf as a child and used the proceeds as part of college savings College completion time at Union/Illinois path: 3.5 years for undergraduate requirements - He finished early and moved on to graduate school Year of PhD: 1969 - Sharp earned his PhD in physical chemistry Year at Caltech postdoc start/end: 1969 to 1971 - Two-year postdoctoral period with Norman Davidson Year MIT arrival: 1974 - Sharp joined MIT and its cancer center environment Year of splicing discovery: 1977 - Discovery of discontinuous genes/RNA splicing at MIT Year Biogen founded: 1978 - Early biotech company formed after Genentech-era conversations Biogen board tenure: 29 years - Sharp served on the board for decades Biogen IPO price: $23/share - He cites the early-1980s public offering Biogen share price later: $4/share - Stock traded down several years after IPO during strategic uncertainty Lab staffing at MIT during splicing era: 3 graduate students and 4 postdocs - Sharp describes his team at the time of discovery Targeted therapeutic focus after restructuring: Beta interferon and Herolog - Biogen narrowed focus under Jim Benson Historical therapeutic impact: Hairy cell leukemia treatment with alpha interferon - Example of an early biologic therapy derived from the company ecosystem

Pivotal Quotes: "you are what you read" — Phil Sharp: Describing how books and a school library shaped his early scientific imagination in a rural setting "one gene, two proteins. Or 10 proteins. Or 30 proteins." — Luke Timmerman: Summarizing the implication of Sharp’s RNA splicing discovery during the interview "when you were emerging from high school and then going to graduate school, have more confidence in yourself" — Phil Sharp: His advice to his younger self at the end of the conversation

Implications: Sharp’s story shows that major scientific and entrepreneurial breakthroughs can emerge from humble origins, disciplined curiosity, and willingness to cross fields. For biotech, it underscores the value of focusing strategy after visionary expansion and the long payoff of foundational platform science.